LC–MS/MS Bioanalysis of Radioligand Therapeutic Drug Candidate for Preclinical Toxicokinetic Assessment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

LC–MS/MS Bioanalysis of Radioligand Therapeutic Drug Candidate for Preclinical Toxicokinetic Assessment

Published:2023-07-04 Issue:28 Volume:95 Page:10812-10819
ISSN:0003-2700
Container-title:Analytical Chemistry
language:en
Short-container-title:Anal. Chem.

Author:

Fu Yunlin¹^ORCID,Farnham James²,Li Wenkui¹,Powers Brendan²,Humphries David²,Picard Franck³

Affiliation:

1. Pharmacokinetic Sciences─Drug Disposition, Novartis Institutes for BioMedical Research, One Health Plaza, East Hanover, New Jersey 07936, United States

2. Labcorp Drug Development, 3301 Kinsman Boulevard, Madison, Wisconsin 53704, United States

3. Pharmacokinetic Sciences─Drug Disposition, Novartis Institutes for BioMedical Research, Basel CH-4056, Switzerland

Publisher

American Chemical Society (ACS)

Subject

Analytical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.analchem.3c02163

Reference17 articles.

1. Cancer statistics, 2022

2. Current Challenges in Cancer Treatment

3. Assessment of the Evolution of Cancer Treatment Therapies

4. Status of PSMA-targeted radioligand therapy in prostate cancer: current data and future trials

5. Update on radionuclide therapy in oncology (Review)

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inclusion of dilution quality control samples in quantitative LC-MS bioanalysis;Bioanalysis;2024-06-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP